Abstract
Inhibitors of differentiation (Id) or DNA binding helix-loop-helix (HLH) proteins are a group of dominant inhibitors of basic HLH transcriptional factors, which act as positive regulators of cell growth or promote excessive proliferation, and also protect cells against drug-induced apoptosis in mammalians. Recently, Id1 has been identified as a common downstream target of several constitutively activated oncogenic tyrosine kinase(TK), such as FLT3/ITD, in leukemia cells. We analyzed Id1 expression as possible prognostic factor in 237 AML patients. High Id1 expression was associated with older age(p=0.009); and with Ftl3/ITD(p=0.003). However, 61% of the patients in the group of FLT3- AML were Id1+, suggesting that other TK are involved. In whole population, high Id1 expression independently predicted shorter disease free survival (DFS)(p=0.05), and overall survival (OS)(p=0.003). In the subgroup of young patients (age'60 years) with normal cytogenetic, Id1+ was, in multivariate analysis, associated with lower CR rates(p=0.02), shorter DFS(p=0.02) and OS(p=0.006).
In conclusion our data provides a new molecular marker for refining the risk classification of AML especially in young patients with normal cytogenetic. Id1- patients with normal cytogenetic should be classified as favourable-risk leukemia. Id1, as a downstream target of constitutively activated TK, could be a suitable candidate for targeted therapy.
No relevant conflicts of interest to declare.
![](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/114/22/10.1182_blood.v114.22.4687.4687/2/m_permbld2009abs02.jpeg?Expires=1724221769&Signature=BesSzkbT2Lro2BUGfVPU7CeNmuAhQENd6ytXGG7acjttXbOU8V6ZsOemZ~YpQcXTfAxDu-ucOaZ448i8A3gOQqsbn1yFvGbdl-j9LLqamagqbmN1osetpxglXfTrfftPARbKJ6VfuXrThCu8jEWwJ7GyitkS-GSmthtJB0qxAJ6kUTlBs6N-F6sQF9LxRPRbnWD9Deg4saAuL2I508c1Vg4EaXRg6nv2Y4rkzmiHI7tRLejK-PfHkTKhfy8F9cUlltZ7r~cJrhz7aiI6rFPtM5-P12ECSjZnFHxNtitgJlp1D3VYxC06iMiS33W~HCMA1gYoDhTp3ktka5VCbz40Ig__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
This icon denotes an abstract that is clinically relevant.
Author notes
Asterisk with author names denotes non-ASH members.